This compound is a chiral pharmaceutical intermediate used in the manufacture of finerenone. It features a dihydronaphthyridine core with multiple functional groups including nitrile, ether, and ester moieties.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2640574-73-6
(S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic Acid
pharmaceutical intermediate
4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylic acid
pharmaceutical intermediate
Methyl 16-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-2-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-3-yl]oxyhexadecanoate
pharmaceutical intermediate
N-(4-(2,2-Dicyano-1-hydroxyvinyl)benzyl)-5-fluoro-2-methoxybenzamide
pharmaceutical intermediate
2,4-Dichloropyridine
pharmaceutical intermediate
TBUO-C20-GAMMA-GLU(AEEA)-OTBU
pharmaceutical intermediate
2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate
pharmaceutical intermediate
Finerenone
pharmaceutical raw material
2-cyanoethyl (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate
AZFZQYUDLXNVMW-HXUWFJFHSA-N
CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)OCCC#N)C3=C(C=C(C=C3)C#N)OC)C
—